Navigation Links
Cell Biosciences Launches New Platform for Multiplex Western Blot Detection
Date:1/5/2011

SANTA CLARA, Calif., Jan. 5, 2011 /PRNewswire/ -- Cell Biosciences, Inc., a provider of innovative protein analysis tools to life science researchers, today announced the launch of the latest addition to their premier line of next-generation imaging products, the FluorChem® M MultiFluor system. This new platform combines highly-sensitive quantitative detection of multicolor fluorescent Western blots with key ease-of-use features aimed at simplifying the laboratory imaging process. MultiFluor Western Blotting kits, a new line of reagents optimized for the FluorChem M, are launching jointly - creating a combined offering that provides a complete solution for multicolor fluorescent imaging.

Multiplex capability enables scientists to obtain more information in a single Western blot than chemiluminescence imaging or film, while also providing greater dynamic and linear range. Multiple proteins can be detected simultaneously and proteins with co-migration patterns are revealed immediately. Additionally, the need to strip and reprobe blots for subsequent detection of other proteins is eliminated, which minimizes protein loss and results in shorter assay times and higher data integrity.  

"The new FluorChem platforms integrate high-performance imaging with true ease of operation, facilitating the transition from darkroom film imaging to bench-top imager," commented Tim Harkness, President and Chief Executive Officer of Cell Biosciences. "Customer response to FluorChem E, our initial market entry in this product line, has been tremendously positive. We sold over 100 FluorChem E units in the first six months, and we believe that FluorChem M will be a key driver for the continued growth of our imaging line."

FluorChem M features intuitive software, touchscreen operation and pre-optimized protocols that let researchers start imaging right out of the box – no training required. Using a unique browser-based interface, scientists can control and monitor image acquisition and access data remotely from any networked computer or mobile WiFi device. Chemiluminescent, colorimetric and UV-excited gels and blots can also be imaged on the system.  

About Cell Biosciences

Cell Biosciences is a private life sciences company focused on defining the future of protein analysis. The Company develops instrumentation systems, software and assay products that drive discoveries in fields ranging from fundamental protein research to biomarker discovery and personalized medicine. With an installed base of over 10,000 systems, its customers include leading research institutions, pharmaceutical and biotechnology companies worldwide. Cell Biosciences is headquartered in Santa Clara, California. For more information, visit www.cellbiosciences.com.


'/>"/>
SOURCE Cell Biosciences, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Frost & Sullivan Presents the 2010 North American Enabling Technology of the Year Award for Surface Functionalization Technologies to Semprus BioSciences
2. Ambit Biosciences Initiates Two Phase I Clinical Trials
3. Catalyst Biosciences Receives Milestone Payment from Pfizer for Progress in Lead Hemostasis Program
4. Cell Biosciences Announces US Patent Issuance
5. Sofie Biosciences Raises $2M to Support Development of Diagnostic Imaging Agents and Devices
6. Sangamo BioSciences Announces Presentation of Phase 2 Data in Amyotrophic Lateral Sclerosis (ALS) at Society for Neuroscience Meeting
7. Regado Biosciences, Inc. Introduces REG3, a Novel Aptamer-Based Inhibitor of Glycoprotein VI and its Matched Active Control Agent, at the American Heart Association (AHA) Scientific Sessions 2010 Meeting
8. Cardio3 BioSciences Announces Positive Outcome of the C-Cure(R) Phase II Clinical Trial in Heart Failure Patients
9. Regado Biosciences, Inc. Presents Pharmacokinetic and Pharmacodynamic (PK/PD) Substudy Results From its Phase 2b RADAR Trial at the American Heart Association (AHA) Scientific Sessions 2010 Meeting
10. Regado Biosciences, Inc. Presents Two Abstracts on the Subcutaneous Depot Formulation of Pegnivacogin, a Nuclease-Stabilized RNA Aptamer, Direct Factor IXa Inhibitor and Part of the REG2 Anticoagulant System, at the American Heart Association (AHA)
11. Magellan Biosciences to Debut Revolutionary New Dynex® Clinical Diagnostics Processing System for Fully Automated ELISA Testing at MEDICA 2010
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/2/2017)... Fla. , Oct. 2, 2017  AllianceRx Walgreens ... company formed by Walgreens and pharmacy benefit manager Prime ... its new brand, which included the unveiling of new ... , as well as at a few other ... the new brand to patients, some of whom will ...
(Date:9/28/2017)... -- Cohen Veterans Bioscience and Early Signal Foundation announce ... home sensors for real-time monitoring of patients with trauma-related ... organization focused on disruptive health solutions for rare disorders ... to record and integrate behavioral, cognitive, physiological and contextual ... ...
(Date:9/25/2017)... R.I. , Sept. 25, 2017  EpiVax, ... assessment, vaccine design, and immune-engineering today announced the ... on the development of personalized therapeutic cancer vaccines. ... has provided exclusive access to enabling technologies to ... Eng., MBA will lead EpiVax Oncology as Chief ...
Breaking Medicine Technology:
(Date:10/13/2017)... LUIS OBISPO, Calif. (PRWEB) , ... October 13, 2017 , ... ... Alzheimer’s or dementia. However, many long-term care insurance companies have a waiver for care ... is the 90-day elimination period, when the family pays for care, is often waived, ...
(Date:10/13/2017)... NY (PRWEB) , ... October 13, 2017 , ... Ellevate ... people in business to advocate for action towards gender equality at their inaugural Summit ... from around the globe, and reached a social audience of over 3 million. To ...
(Date:10/13/2017)... ... October 13, 2017 , ... Yisrayl Hawkins, Pastor and Overseer ... one of the most popular and least understood books in the Holy Scriptures, Revelation. ... descriptions that have baffled scholars for centuries. Many have tossed it off as mere ...
(Date:10/13/2017)... ... October 13, 2017 , ... Coveros, a leader ... been awarded a contract by the Center for Medicare and Medicaid Services (CMS). ... the enterprise use of Agile methodologies in a consistent and high value manner ...
(Date:10/13/2017)... ... October 13, 2017 , ... “America On The Brink”: the Christian history of ... Brink” is the creation of published author, William Nowers. Captain Nowers and his ... veteran, he spent thirty years in the Navy. Following his career as a ...
Breaking Medicine News(10 mins):